Revenue Breakdown

Financials in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	2012 - 2021
Period Ending	Sep '25 Sep 30, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	2012 - 2021
North American OTC Healthcare Revenue	931.22M	960.01M	Log In	Log In	Log In	Upgrade
International OTC Healthcare Revenue	179.26M	177.75M	Log In	Log In	Log In	Upgrade
Revenue (Total)	1.11B	1.14B	Log In	Log In	Log In	Upgrade

Revenue Breakdown 2

Financials in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	2012 - 2021
Period Ending	Sep '25 Sep 30, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	2012 - 2021
Analgesics Revenue	118.85M	117.70M	Log In	Log In	Log In	Upgrade
Cough & Cold Revenue	102.53M	106.21M	Log In	Log In	Log In	Upgrade
Women's Health Revenue	234.86M	236.83M	Log In	Log In	Log In	Upgrade
Gastrointestinal Revenue	259.85M	255.94M	Log In	Log In	Log In	Upgrade
Eye & Ear Care Revenue	158.89M	183.32M	Log In	Log In	Log In	Upgrade
Dermatologicals Revenue	125.54M	128.95M	Log In	Log In	Log In	Upgrade
Oral Care Revenue	96.64M	95.03M	Log In	Log In	Log In	Upgrade
Other OTC Revenue	13.31M	13.78M	Log In	Log In	Log In	Upgrade
Revenue (Total)	1.11B	1.14B	Log In	Log In	Log In	Upgrade

Financials in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	2012 - 2021
Period Ending	Sep '25 Sep 30, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	2012 - 2021
North American OTC Healthcare Gross Margin	521.16M	531.14M	Log In	Log In	Log In	Upgrade
International OTC Healthcare Gross Margin	101.81M	103.32M	Log In	Log In	Log In	Upgrade
Gross Profit (Total)	622.97M	634.46M	Log In	Log In	Log In	Upgrade

Financials in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	2012 - 2021
Period Ending	Sep '25 Sep 30, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	2012 - 2021
North American OTC Healthcare Contribution Margin	399.39M	401.71M	Log In	Log In	Log In	Upgrade
International OTC Healthcare Contribution Margin	75.00M	77.03M	Log In	Log In	Log In	Upgrade
Gross Profit (Other)	148.59M	155.72M	Log In	Log In	Log In	Upgrade
Gross Profit (Total)	622.97M	634.46M	Log In	Log In	Log In	Upgrade

Updated Sep 30, 2025. Data Source: Fiscal.ai.